Class summary at a glance.

Every drug in the Serotonin-4 Receptor Agonist class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $103.9Mcombined across class
Total Rx claims: 145K43K unique beneficiaries
Generic mfrs (active): 16across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Prucalopride

Brand: MOTEGRITY · 145K Part D claims (CY24) · 43K beneficiaries · First FDA approval: 2018-12-14

16 generic mfrs 2 plans require PA

Low NADAC$0.705

→

Avg plan cost$2.15

Part D spend $103.9M 3× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.